Literature DB >> 18367526

Arrangement of L2 within the papillomavirus capsid.

Christopher B Buck1, Naiqian Cheng, Cynthia D Thompson, Douglas R Lowy, Alasdair C Steven, John T Schiller, Benes L Trus.   

Abstract

Papillomaviruses are a family of nonenveloped DNA tumor viruses. Some sexually transmitted human papillomavirus (HPV) types, including HPV type 16 (HPV16), cause cancer of the uterine cervix. Papillomaviruses encode two capsid proteins, L1 and L2. The major capsid protein, L1, can assemble spontaneously into a 72-pentamer icosahedral structure that closely resembles native virions. Although the minor capsid protein, L2, is not required for capsid formation, it is thought to participate in encapsidation of the viral genome and plays a number of essential roles in the viral infectious entry pathway. The abundance of L2 and its arrangement within the virion remain unclear. To address these questions, we developed methods for serial propagation of infectious HPV16 capsids (pseudoviruses) in cultured human cell lines. Biochemical analysis of capsid preparations produced using various methods showed that up to 72 molecules of L2 can be incorporated per capsid. Cryoelectron microscopy and image reconstruction analysis of purified capsids revealed an icosahedrally ordered L2-specific density beneath the axial lumen of each L1 capsomer. The relatively close proximity of these L2 density buttons to one another raised the possibility of homotypic L2 interactions within assembled virions. The concept that the N and C termini of neighboring L2 molecules can be closely apposed within the capsid was supported using bimolecular fluorescence complementation or "split GFP" technology. This structural information should facilitate investigation of L2 function during the assembly and entry phases of the papillomavirus life cycle.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18367526      PMCID: PMC2395198          DOI: 10.1128/JVI.02726-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Propagation, infection, and neutralization of authentic HPV16 virus.

Authors:  Margaret E McLaughlin-Drubin; Neil D Christensen; Craig Meyers
Journal:  Virology       Date:  2004-05-01       Impact factor: 3.616

2.  Structural polypeptides of rabbit, bovine, and human papillomaviruses.

Authors:  M Favre
Journal:  J Virol       Date:  1975-05       Impact factor: 5.103

3.  Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes.

Authors:  R B Roden; W H Yutzy; R Fallon; S Inglis; D R Lowy; J T Schiller
Journal:  Virology       Date:  2000-05-10       Impact factor: 3.616

4.  Interactions between papillomavirus L1 and L2 capsid proteins.

Authors:  Renée L Finnen; Kimberly D Erickson; Xiaojiang S Chen; Robert L Garcea
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

5.  Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression.

Authors:  Patricia M Day; Carl C Baker; Douglas R Lowy; John T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-21       Impact factor: 11.205

6.  Characterization of a new type of human papillomavirus that causes skin warts.

Authors:  G Orth; M Favre; O Croissant
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

Review 7.  Classification of papillomaviruses.

Authors:  Ethel-Michele de Villiers; Claude Fauquet; Thomas R Broker; Hans-Ulrich Bernard; Harald zur Hausen
Journal:  Virology       Date:  2004-06-20       Impact factor: 3.616

8.  Differential antibody responses to a distinct region of human papillomavirus minor capsid proteins.

Authors:  Monica E Embers; Lynn R Budgeon; Timothy D Culp; Cynthia A Reed; Martin D Pickel; Neil D Christensen
Journal:  Vaccine       Date:  2004-01-26       Impact factor: 3.641

9.  Efficient intracellular assembly of papillomaviral vectors.

Authors:  Christopher B Buck; Diana V Pastrana; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

Review 10.  Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia.

Authors:  Mark Schiffman; Susanne Krüger Kjaer
Journal:  J Natl Cancer Inst Monogr       Date:  2003
View more
  157 in total

1.  A cryo-electron microscopy study identifies the complete H16.V5 epitope and reveals global conformational changes initiated by binding of the neutralizing antibody fragment.

Authors:  Hyunwook Lee; Sarah A Brendle; Stephanie M Bywaters; Jian Guan; Robert E Ashley; Joshua D Yoder; Alexander M Makhov; James F Conway; Neil D Christensen; Susan Hafenstein
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Subunit interactions in bovine papillomavirus.

Authors:  Matthias Wolf; Robert L Garcea; Nikolaus Grigorieff; Stephen C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-22       Impact factor: 11.205

3.  Structural basis of oligosaccharide receptor recognition by human papillomavirus.

Authors:  Jhimli Dasgupta; Malgorzata Bienkowska-Haba; Marcos E Ortega; Hetalkumar D Patel; Sabrina Bodevin; Dorothe Spillmann; Brooke Bishop; Martin Sapp; Xiaojiang S Chen
Journal:  J Biol Chem       Date:  2010-11-29       Impact factor: 5.157

4.  Disulfide linkages mediating nucleocapsid protein dimerization are not required for porcine arterivirus infectivity.

Authors:  Rong Zhang; Chunyan Chen; Zhi Sun; Feifei Tan; Jinshan Zhuang; Debin Tian; Guangzhi Tong; Shishan Yuan
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

5.  Identification of a dendrimeric heparan sulfate-binding peptide that inhibits infectivity of genital types of human papillomaviruses.

Authors:  Manuela Donalisio; Marco Rusnati; Andrea Civra; Antonella Bugatti; Donatella Allemand; Giovanna Pirri; Andrea Giuliani; Santo Landolfo; David Lembo
Journal:  Antimicrob Agents Chemother       Date:  2010-07-19       Impact factor: 5.191

6.  The transcription factors TBX2 and TBX3 interact with human papillomavirus 16 (HPV16) L2 and repress the long control region of HPVs.

Authors:  Marc A Schneider; Konstanze D Scheffer; Timo Bund; Fatima Boukhallouk; Carsten Lambert; Cristina Cotarelo; Gert O Pflugfelder; Luise Florin; Gilles A Spoden
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

Review 7.  Concepts of papillomavirus entry into host cells.

Authors:  Patricia M Day; Mario Schelhaas
Journal:  Curr Opin Virol       Date:  2013-12-14       Impact factor: 7.090

8.  A transmembrane domain and GxxxG motifs within L2 are essential for papillomavirus infection.

Authors:  Matthew P Bronnimann; Janice A Chapman; Chad K Park; Samuel K Campos
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

9.  Human Papillomavirus Major Capsid Protein L1 Remains Associated with the Incoming Viral Genome throughout the Entry Process.

Authors:  Stephen DiGiuseppe; Malgorzata Bienkowska-Haba; Lucile G M Guion; Timothy R Keiffer; Martin Sapp
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

Review 10.  Papillomavirus prophylactic vaccines: established successes, new approaches.

Authors:  M Saveria Campo; Richard B S Roden
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.